Influenza vaccination for immunocompromised patients: Systematic review and meta-analysis from a public health policy perspective

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Beck, Charles R ^a   McKenzie, Bruce C ^a   Hashim, Ahmed B ^a   Harris, Rebecca C ^b   Zanuzdana, Arina ^c   Agboado, Gabriel ^d   Orton, Elizabeth ^a   Béchard Evans, Laura ^b   Morgan, Gemma ^e   Stevenson, Charlotte ^e   Weston, Rachel ^e   Mukaigawara, Mitsuru ^b   Enstone, Joanne ^a   Augustine, Glenda ^f   Butt, Mobasher ^g   Kim, Sophie ^h   Puleston, Richard ^a   Dabke, Girija ^e   Howard, Robert ⁱ   O'Boyle, Julie ⁱ   O'Brien, Mary ^j   Ahyow, Lauren ^f   Denness, Helene ^k   Farmer, Siobhan ^l   Figureroa, Jose ^m   Fisher, Paul ⁿ   Greaves, Felix ^o   Haroon, Munib ^p   Haroon, Sophie ^e   Hird, Caroline ^e   Isba, Rachel ^q   Ishola, David A ^r   Kerac, Marko ^r   Parish, Vivienne ^s   Roberts, Jonathan ^e   Rosser, Julia ^t   Theaker, Sarah ^u   Wallace, Dean ^u   Wigglesworth, Neil ^v   Lingard, Liz ^e   Vinogradova, Yana ^a   Horiuchi, Hiroshi ^w   Peñalver, Javier ^b   Nguyen Van Tam, Jonathan S ^a   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c BIELEFELD UNIVERSITY   (Germany)

^d Public Health Directorate   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f Public Health Directorate   (United Kingdom)

^g Worthing Hospital   (United Kingdom)

^h HARVARD LAW SCHOOL   (United States)

ⁱ Public Health Directorate   (United Kingdom)

^j Public Health   (United Kingdom)

^k National Health Services Derbyshire County   (United Kingdom)

^l Public Health   (United Kingdom)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ Public Health Directorate   (United Kingdom)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p Leicester Partnership Trust   (United Kingdom)

^q LANCASTER UNIVERSITY   (United Kingdom)

^r UNIVERSITY COLLEGE LONDON   (United Kingdom)

^s Public Health Directorate   (United Kingdom)

^t Public Health Directorate   (United Kingdom)

^u Public Health Directorate   (United Kingdom)

^v NHS East Lancashire   (United Kingdom)

^w TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PLACEBO;

ARTICLE; DRUG FEVER; ECCHYMOSIS; HEALTH CARE POLICY; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; INFORMATION PROCESSING; LABORATORY TEST; MALAISE; META ANALYSIS; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SEASONAL INFLUENZA; SEROCONVERSION; SHIVERING; SKIN INDURATION; SYSTEMATIC REVIEW; IMMUNOLOGY; PUBLIC HEALTH; REVIEW;

HEALTH POLICY; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA VACCINES; PLACEBOS; PUBLIC HEALTH;

EID: 84055216970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029249     Document Type: Article

References (258)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. (2004) Influenza-associated hospitalizations in the United States. JAMA 292: 1333-1340.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
3. Viboud C, Miller M, Olson D, Osterholm M, Simonsen L, (2010) Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLoS Curr pp. RRN1153.
4. Kunisaki KM, Janoff EN, (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9: 493-504.
5. Lee N, Chan PK, Hui DS, Rainer TH, Wong E, et al. (2009) Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 200: 492-500.
6. Leekha S, Zitterkopf NL, Espy MJ, Smith TF, Thompson RL, et al. (2007) Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 28: 1071-1076.
7. Giannella M, Alonso M, Garcia de Viedma D, Roa PL, Catalan P, et al. (2010) Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect doi:10.1111/j.1469-0691.2010.03399.x.
8. Mohty B, Thomas Y, Vukicevic M, Nagy M, Levrat E, et al. (2011) Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT. Bone Marrow Transplant doi:10.1038/bmt.2011.1057.
9. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, et al. (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis 15: 552-560.
10. Ring A, Marx G, Steer C, Harper P, (2002) Influenza vaccination and chemotherapy: a shot in the dark? Support Care Cancer 10: 462-465.
11. Goossen GM, Kremer LCM, Van De Wetering MD, (2009) Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev pp. CD006484.
12. Atashili J, Kalilani L, Adimora AA, (2006) Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis. BMC Infect Dis 6: 138.
13. Anema A, Mills E, Montaner J, Brownstein JS, Cooper C, (2008) Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis (Provisional abstract). HIV Medicine pp. 57-61.
14. Salisbury D, Ramsay M, Noakes K, eds. (2006) Chapter 19 Influenza (updated January 2011). Immunisation against infectious disease London The Stationary Office pp. 185-208.
15. Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, et al. (2010) Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill 15: pii = 19571.
16. Campbell CN, Mytton OT, McLean EM, Rutter PD, Pebody RG, et al. (2010) Hospitalization in two waves of pandemic influenza A(H1N1) in England. Epidemiol Infect doi:10.1017/S0950268810002657.
17. Wilking H, Buda S, von der Lippe E, Altmann D, Krause G, et al. (2010) Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill 15: pii = 19741.
18. Chironna M, Tafuri S, Santoro N, Prato R, Quarto M, et al. (2010) A nosocomial outbreak of 2009 pandemic influenza A(H1N1) in a paediatric oncology ward in Italy, October-November 2009. Euro Surveill 15: pii = 19454.
19. Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, et al. (2010) Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect 61: 270-272.
20. Kharfan-Dabaja MA, Velez A, Richards K, Greene JN, Field T, et al. (2010) Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol 91: 124-127.
21. Enstone JE, Myles PR, Openshaw PJ, Gadd EM, Lim WS, et al. (2011) Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010. Emerg Infect Dis 17: 592-598.
22. Beck C, McKenzie B, Hashim A, Nguyen-Van-Tam J, (2011) Clinical effectiveness of influenza vaccination for immunocompromised patients: a systematic review and meta-analysis. CRD Register pp. CRD42011001226.
23. World Health Organization (2010) WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and other Influenza Viruses. Part I Recommendations. World Health Organization.
24. Committee for Proprietary Medicinal Products (1997) Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96 London European Agency for the Evaluation of Medicinal Products.
25. ICH Expert Working Group. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6(R1). [Online]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf [Accessed 19th November 2011].
26. Higgins J, Green S, eds. (2009) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 [updated September 2009] ed The Cochrane Collaboration.
27. Downs SH, Black N, (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52: 377-384.
28. West S, King V, Carey T, Lohr K, McKoy N, et al. (2002) Systems to rate the strength of scientific evidence. Evidence report/technology appraisal number 47. Agency for Healthcare Research and Quality.
29. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535.
30. Human Development Report 2010 team (2010) The Real Wealth of Nations: Pathways to Human Development New York, USA United Nations Development Agency.
31. Delafond P, (1990) Vaccins: pour ou contre? Medecine Douce pp. 18-76.
32. Mesle F, Vallin J, (1999) Le rôle des vaccinations dans la baisse de la mortalité. Dossiers et Recherche pp. 16.
33. Pereira G, Tondo Á, (2009) Vacunación en el paciente con virus de inmunodeficiencia humana. Arch Med Interna 31: 20-22.
34. Falchetti, Magnani, (2000) Flu vaccine in patients with orthotopic heart transplantation. Ital Heart J 1: 25.
35. Hanania NA, Sockrider M, Wise R, Castro M, Tonascia J, et al. (2002) Immune response to influenza vaccine in patients with asthma- lack of effect of corticosteroid therapy. Am J Respir Crit Care Med pp. A561.
36. Abu-Shakra M, Press J, Sukenik S, Buskila D, (2002) Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies. Clin Rheumatol 21: 369-372.
37. Admon D, Engelhard D, Strauss N, Goldman N, Zakay-Rones Z, (1997) Antibody response to influenza immunization in patients after heart transplantation. Vaccine 15: 1518-1522.
38. Allison JE, Glezen WP, Taber LH, Paredes A, Webster RG, (1977) Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children. J Infect Dis 136 (Suppl): S672-S676.
39. Altamirano-Diaz L, West L, Humar A, Ely L, Urschel S, et al. (2011) Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients. Pediatr Transplant 15: 172-175.
40. Amendola A, Boschini A, Colzani D, Anselmi G, Oltolina A, et al. (2001) Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users. J Med Virol 65: 644-648.
41. Anderson H, Petrie K, Berrisford C, Charlett A, Thatcher N, et al. (1999) Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer 80: 219-220.
42. Anema A, Mills E, Montaner J, Brownstein JS, Cooper C, (2008) Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis. HIV Med 9: 57-61.
43. Antonio R, Delogu G, Sali M, Coccia P, Pierri F, et al. (2010) Efficacy of influenza A(H1N1v) vaccination in children with cancer. Pediatr Blood Cancer 55: 973.
44. Avetisyan G, Aschan J, Hassan M, Ljungman P, (2008) Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation. Transplantation 86: 257-263.
45. Ballet C, Roussey-Kesler G, Aubin JT, Brouard S, Giral M, et al. (2006) Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. Am J Transplant 6: 2796-2801.
46. Banic S, Koren S, Tomazic J, Vidmar L, Ihan A, et al. (2001) Influenza vaccination of human immunodeficiency virus 1-infected patients receiving antiretroviral therapy. Acta Virol 45: 39-44.
47. Bate J, Yung C, Hoschler K, Sheasby L, Taj M, et al. (2010) Immungenicity of novel influenza A (H1N1) vaccine in UK children with cancer: a single centre study. Pediatr Blood Cancer 55: 823.
48. Bate J, Yung CF, Hoschler K, Sheasby L, Morden J, et al. (2010) Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. Clin Infect Dis 51: e95-e104.
49. Bedognetti D, Zoppoli G, Massucco C, Zupo S, Sertoli MR, et al. (2009) Impaired humoral response to influenza vaccine and prolonged B memory cell depletion as a consequence of rituximab-based immunochemotherapy in non-hodgkin lymphoma patients. J Immunother 32: 992-993.
50. Bedognetti D, Zoppoli G, Zanardi E, Massucco C, Sertoli MR, et al. (2010) Prolonged lack of humoral response to influenza vaccine associated with a persistent depletion of B memory cells in non hodgkin's lymphoma patients treated with rituximab-containing immunochemotherapy. Clin Immunol 135: S84.
51. Bektas O, Karadeniz C, Oguz A, Berberoglu S, Yilmaz N, et al. (2007) Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors. Pediatr Blood Cancer 49: 914-917.
52. Bellei NCJ, Carraro E, Castelo A, Granato CFH, (2006) Risk factors for poor immune response to influenza vaccination in elderly people. Braz J Infect Dis 10: 269-273.
53. Benne CA, Kroon FP, Harmsen M, Tavares L, Kraaijeveld CA, et al. (1998) Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals. Clin Diagn Lab Immunol 5: 114-117.
54. Bergeron A, (2010) Investigations of influenza vaccination in kidney and lung transplant populations [MSc thesis]Edmonton, AlbertaUniversity of Alberta.
55. Bickel M, Wieters I, Khaykin P, Nisius G, Haberl A, et al. (2010) Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. AIDS 24: F31-F35.
56. Biselli R, Fagiolo U, Nisini R, Paganelli R, Doffizi G, et al. (1995) Humoral response to influenza hemagglutinin: oligoclonal spectrotype and failure of thymopentin as immunoadjuvant. Gerontology 41: 3-10.
57. Blumberg EA, Albano C, Pruett T, Isaacs R, Fitzpatrick J, et al. (1996) The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 22: 295-302.
58. Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC, (1998) Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 17: 1075-1080.
59. Borella L, Webster RG, (1971) The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res 31: 420-426.
60. Brakemeier S, Schweiger B, Glander P, Diekmann F, Neuma-Yer HH, et al. (2010) A single dose of an adjuvanted influenza A H1N1 vaccine (pandemrix (R)) does not provide a protective immune response in the majority of renal transplant recipients. Transpl Int 23: 0050.
61. Briggs WA, Rozek RJ, Migdal SD, Shillis JL, Brackett RG, et al. (1980) Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 92: 471-477.
62. Brown AE, Steinherz PG, Miller DR, Armstrong D, Kellick MG, et al. (1982) Immunization against influenza in children with cancer: results of a three-dose trial. J Infect Dis 145: 126.
63. Brunell PA, (1977) Immunologic response of immunosuppressed children to influenza vaccine. MMWR Recomm Rep 26: 54.
64. Brydak LB, Calbecka M, (1999) Immunogenicity of influenza vaccine in patients with hemato-oncological disorders. Leuk Lymphoma 32: 369-374.
65. Brydak LB, Guzy J, Starzyk J, Machala M, Gozdz SS, (2000) Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer 9: 65-68.
66. Brydak LB, Hryniewicz HJ, Machala M, Horban A, (1999) Humoral response to influenza vaccination in HIV-infected patients. Clin Drug Invest 17: 441-449.
67. Brydak LB, Machala M, Centkowski P, Warzocha K, Bilinski P, (2006) Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine 24: 6620-6623.
68. Brydak LB, Machala M, Laguna P, Rokicka-Milewska R, (2004) Antibody response to influenza vaccination in splenectomized patients in Poland. J Clin Immunol 24: 225-236.
69. Brydak LB, Rokicka-Milewska R, Machala M, Jackowska T, (2000) Studies on the humoral immune response to hemagglutinin of influenza vaccine in children with acute lymphoblastic leukemia after chemotherapy treatment. Int J Pediatr Hematol Oncol 7: 29-40.
70. Brydak LB, Rokicka-Milewska R, Machala M, Jackowska T, Sikorska-Fic B, (1998) Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatr Infect Dis J 17: 125-129.
71. Bucalossi A, Marotta G, Galieni P, Bigazzi C, Valenzin PE, et al. (1995) Immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol 93: 56.
72. Burbach G, Bienzle U, Stark K, Rayes N, Neuhaus R, et al. (1999) Influenza vaccination in liver transplant recipients. Transplantation 67: 753-755.
73. Candon S, Thervet E, Lebon P, Suberbielle C, Lima C, et al. (2009) Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant Recipients. Am J Transplant 9: 658.
74. Candon S, Thervet E, Lebon P, Suberbielle C, Zuber J, et al. (2009) Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 9: 2346-2354.
75. Canestri A, Krivine A, Assoumou L, Le Corre M, Rozenberg F, et al. (2010) Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients. AIDS 24: 2887-2889.
76. Carroll RN, Marsh SD, O'Donoghue EP, Breeze DC, Shackman R, (1974) Response to influenza vaccine by renal transplant patients. BMJ 2: 701-703.
77. Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, et al. (2003) The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 37: 71-76.
78. Centkowski P, Brydak L, Machala M, Kalinka-Warzocha E, Blasinska-Morawiec M, et al. (2007) Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma. J Clin Immunol 27: 339-346.
79. Chadha MK, Fakih MG, Tian L, Mashtare T, Nesline M, et al. (2009) Effect of 25 hydroxy vitamin D status on serological response to influenza vaccine in cancer patients. J Clin Oncol 27: e20575.
80. Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, et al. (1994) Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 13: 206-211.
81. Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, et al. (1994) Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 21: 1203-1206.
82. Chebotareva TA, Mazankova LN, Malinovskaya VV, Kariaeva SK, Lazarev VV, (2009) Clinical effectiveness of prevention of influenza and ARVI among children living in ecologically disadvantaged regions. Pediatrija 88: 104-111.
83. Chisholm J, Howe K, Taj M, Zambon M, (2005) Influenza immunisation in children with solid tumours. Eur J Cancer 41: 2280-2287.
84. Chisholm JC, Devine T, Charlett A, Pinkerton CR, Zambon M, (2001) Response to influenza immunisation during treatment for cancer. Arch Dis Child 84: 496-500.
85. Danziger-Isakov L, Cherkassky L, Siegel H, McManamon M, Kramer K, et al. (2010) Effects of influenza immunization on humoral and cellular alloreactivity in humans. Transplantation 89: 838-844.
86. de Lavallade H, Garland P, Sekine T, Hoschler K, Marin D, et al. (2011) Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica 96: 307-314.
87. de Roux A, Marx A, Burkhardt O, Schweiger B, Borkowski A, et al. (2006) Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. Vaccine 24: 1537-1542.
88. DeBruyn JCC, (2010) Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease [MSc thesis]Calgary, AlbertaUniversity of Calgary.
89. Del Porto F, Lagana B, Biselli R, Donatelli I, Campitelli L, et al. (2006) Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 24: 3217-3223.
90. Dengler TJ, Strnad N, Buhring I, Zimmermann R, Girgsdies O, et al. (1998) Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66: 1340-1347.
91. Dopp JM, Wiegert NA, Moran JJ, Francois ML, Radford KL, et al. (2009) Effect of annual influenza immunization on antibody response in lung transplant patients. Prog Transplant 19: 153-159.
92. Dorrell L, Hassan I, Marshall S, Chakraverty P, Ong E, (1997) Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers. Int J STD AIDS 8: 776-779.
93. Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ, (2001) Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl 7: 311-313.
94. Durando P, Fenoglio D, Boschini A, Ansaldi F, Icardi G, et al. (2008) Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and-seronegative adults. Clin Vaccine Immunol 15: 253-259.
95. Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, et al. (1996) Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 10: 556-560.
96. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, et al. (1993) Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 11: 1-5.
97. Esposito S, Cecinati V, Scicchitano B, Delvecchio GC, Santoro N, et al. (2010) Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy. Vaccine 28: 1558-1565.
98. Feery BJ, Sullivan JR, Hurley TH, Evered MG, (1977) Immunization with influenza vaccine in patients with haematological malignant disease. Med J Aust 1: 292-294.
99. Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, et al. (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65: 191-194.
100. Fowke KR, Damico R, Chernoff DN, Pottage JC, Benson CA, et al. (1997) Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS 11: 1013-1021.
101. Fraund S, Wagner D, Pethig K, Drescher J, Girgsdies OE, et al. (1999) Influenza vaccination in heart transplant recipients. J Heart Lung Transplant 18: 220-225.
102. Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, et al. (1999) Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 28: 541-547.
103. Furth SL, Neu AM, McColley SA, Case B, Steinhoff M, et al. (1995) Immune response to influenza vaccination in children with renal disease. Pediatr Nephrol 9: 566-568.
104. Gabay C, Meier S, Gascon D, Posfay-Barbe K, Combescure C, et al. (2010) The influence of immunosuppressive therapy and underlying diseases on vaccine responses to influenza A H1N1/09 vaccines in inflammatory rheumatic diseases. Swiss Med Wkly 140: 7S.
105. Gandhi MK, Egner W, Sizer L, Inman I, Zambon M, et al. (2001) Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant 28: 775-781.
106. Ganz PA, Shanley JD, Cherry JD, (1978) Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer 42: 2244-2247.
107. Gelinck LB, Teng YK, Rimmelzwaan GF, van den Bemt BJ, Kroon FP, et al. (2007) Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 66: 1402-1403.
108. Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, et al. (2008) The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 67: 713-716.
109. Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ, (1996) The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis 174: 1332-1336.
110. Grekas D, Alivanis P, Kiriazopoulou V, Dioudis C, Sioulis A, et al. (1993) Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 31: 553-556.
111. Gribabis DA, Panayiotidis P, Boussiotis VA, Hannoun C, Pangalis GA, (1994) Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol 91: 115-118.
112. Gross PA, Lee H, Wolff JA, Hall CB, Minnefore AB, et al. (1978) Influenza immunization in immunosuppressed children. J Pediatr 92: 30-35.
113. Gunthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, et al. (2000) Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis 181: 522-531.
114. Hajiabdolbaghi M, Jam S, SeyedAlinaghi S, Jafari S, Badie BM, et al. (2010) Adverse reactions of trivalent influenza vaccine in HIV-infected individuals. Acta Medica Iranica 48: 95-100.
115. Halasa N, Englund J, Nachman S, Weinberg G, Huber V, et al. (2009) Safety of live attenuated of live attenuated influenza vaccine in mild to moderately immunocompromised children with children. Acta Paediatr 98: 151-152.
116. Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, et al. (2004) Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 113: 717-724.
117. Hayney MS, Moran J, Wiegert NA, Burlingham WJ, (2008) Lung transplant patients' T cell responses to influenza vaccine viruses between seasons. Vaccine 26: 2596-2600.
118. Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB, (2004) Influenza vaccine antibody responses in lung transplant recipients. Prog Transplant 14: 346-351.
119. Hodges GR, Davis JW, Lewis HD Jr, Whittier FC Jr, Siegel CD, et al. (1979) Response to influenza A vaccine among high-risk patients. South Med J 72: 29-32.
120. Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, et al. (2009) Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology 48: 1294-1299.
121. Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, et al. (2009) Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum 60: 2438-2447.
122. Hsieh YC, Lu MY, Kao CL, Chiang BL, Lin DT, et al. (2002) Response to influenza vaccine in children with leukemia undergoing chemotherapy. J Formos Med Assoc 101: 700-704.
123. Huang KL, Armstrong JA, Ho M, (1983) Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine. Infect Immun 40: 421-424.
124. Huang KL, Ruben FL, Rinaldo CR Jr, Kingsley L, Lyter DW, et al. (1987) Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA 257: 2047-2050.
125. Huengsberg M, Chakraverty MP, Cooper G, Shahmanesh M, (1995) Response to influenza immunisation in asymptomatic HIV infected men. Genitourin Med 71: 355-357.
126. Ioniţǎ E, Gherghina I, Lupulescu E, Alexandrescu V, Tabra ME, (1998) The response in hemagglutinoinhibiting antibodies following influenza vaccination of HIV-infected children. Roum Arch Microbiol Immunol 57: 53-57.
127. Iorio AM, Alatri A, Francisci D, Preziosi R, Neri M, et al. (1997) Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and-seronegative ex-intravenous drug users. Vaccine 15: 97-102.
128. Isbel NM, Smith KGC, Leydon JA, Walker RG, Becker GJ, (1997) Mycophenolate mofetil suppresses the humoral response to influenza vaccination in renal transplant recipients [abstract]. Nephrology 3: S327.
129. Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, et al. (2011) Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 17: 434-438.
130. Kaine JL, Kivitz AJ, Birbara C, Luo AY, (2007) Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 34: 272-279.
131. Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Tsitsami E, Kyriazopoulou-Dalaina V, (2001) Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol 19: 589-594.
132. Kapetanovic MC, Saxne T, Nilsson JA, Geborek P, (2007) Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology 46: 608-611.
133. Keshtkar-Jahromi M, Argani H, Rahnavardi M, Mirchi E, Atabak S, et al. (2008) Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol 28: 654-660.
134. Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D, (2000) Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation 69: 2449-2451.
135. Kimball P, Verbeke S, Tolman D, (2001) Influenza vaccination among heart transplant recipients. Transplant Proc 33: 1785-1786.
136. King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, et al. (2001) Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. Pediatr Infect Dis J 20: 1124-1131.
137. King JC Jr, Treanor J, Fast PE, Wolff M, Yan L, et al. (2000) Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis 181: 725-728.
138. Knysz B, Brydak LB, Inglot M, Gladysz A, (2001) The response to vaccination against influenza in the season 1991/92 in HIV-1 infected persons. Problemy HIV i AIDS 7: 29-34.
139. Kosalaraksa P, Srirompotong U, Newman R, Lumbiganon P, Wood JM, Serological response to influenza vaccine in HIV-infected children in orphanages. 2nd Thailand Human Influenza Research Meeting, 21-22 October 2009, Bangkok, Thailand.
140. Kostyanaya IE, Meisner AF, Aksenova VA, Baturo AP, (2002) Experience in administration of the vaccines "Pneumo 23" and "VAXIGRIP" among children at risk infected with Mycobacterium tuberculosis. Bulleten Vakzinazija 1: [epub].
141. Kroon FP, Rimmelzwaan GF, Roos MT, Osterhaus AD, Hamann D, et al. (1998) Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 12: F217-F223.
142. Kroon FP, van Dissel JT, de Jong JC, van Furth R, (1994) Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 8: 469-476.
143. Kroon FP, van Dissel JT, de Jong JC, Zwinderman K, van Furth R, (2000) Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 18: 3040-3049.
144. Kubiet MA, Gonzalez-Rothi RJ, Cottey R, Bender BS, (1996) Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest 110: 367-370.
145. Kubota T, Nii T, Nanki T, Kohsaka H, Harigai M, et al. (2007) Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis. Mod Rheumatol 17: 531-533.
146. Kudo M, Onuma S, Kamio T, Endo Y, Tanaka H, et al. (2005) Efficacy of influenza vaccination in children with renal diseases undergone immunosuppressive therapy. Nihon Shoni Jinzobyo Gakkai Zasshi 18: 21-25.
147. Kumar D, Bergeron A, Hidalgo L, Campbell P, Wasilenko S, et al. (2010) Cell-Mediated Immune Responses to Influenza Vaccination in Renal Transplant Recipients. Am J Transplant 10: 207-207.
148. Kumar D, Bergeron A, Humar A, Hidalgo L, Manuel O, et al. (2010) Does influenza vaccination induce de novo HLA alloantibody formation in transplant recipients? Am J Transplant 10: 207-208.
149. Kumar SS, Ventura AK, VanderWerf B, (1978) Influenza vaccination in renal transplant recipients. JAMA 239: 840-842.
150. Lange B, Shapiro SA, Waldman MT, Proctor E, Arbeter A, (1979) Antibody responses to influenza immunization of children with acute lymphoblastic leukemia. J Infect Dis 140: 402-406.
151. Lawal A, Basler C, Branch A, Gutierrez J, Schwartz M, et al. (2004) Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant 4: 1805-1809.
152. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, et al. (1993) Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis 12: 778-782.
153. Louie JS, Nies KM, Shoji KT, Fraback RC, Abrass C, et al. (1978) Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med 88: 790-792.
154. Lu CC, Wang YC, Lai JH, Lee TSH, Lin HT, et al. (2011) A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: Safety and immunity. Vaccine 29: 444-450.
155. Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, et al. (2009) Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 104: 444-453.
156. Lyall EG, Charlett A, Watkins P, Zambon M, (1997) Response to influenza virus vaccination in vertical HIV infection. Arch Dis Child 76: 215-218.
157. Macias J, Pineda JA, Leal M, Abad MA, Delgado J, et al. (2001) HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination. Eur J Clin Microbiol Infect Dis 20: 46-48.
158. Madan RP, Tan M, Fernandez-Sesma A, Moran TM, Emre S, et al. (2008) A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 46: 712-718.
159. Magnani G, Falchetti E, Pollini G, Bacchi-Reggiani L, Grigioni F, et al. (2005) Safety and efficacy of two types of influenza vaccination in heart transplant recipients: A prospective randomised controlled study. J Heart Lung Transplant 24: 588-592.
160. Malaspina A, Moir S, Orsega SM, Vasquez J, Miller NJ, et al. (2005) Compromised B cell responses in influenza vaccination in HIV-infected individuals. J Infect Dis 191: 1442-1450.
161. Malleson PN, Tekano JL, Scheifele DW, Weber JM, (1993) Influenza immunization in children with chronic arthritis: A prospective study. J Rheumatol 20: 1769-1773.
162. Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, et al. (2007) Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 5: 851-856.
163. Marczynska M, Brydak LB, Machala M, Oldakowska A, Zegadlo M, (2001) Influenza vaccination in HIV-infected children. Acta Paediatr 90: 466-467.
164. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, et al. (2005) Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer 45: 831-837.
165. Mauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, et al. (1995) Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 127: 957-960.
166. Mazza JJ, Yale SH, Arrowood JR, Reynolds CE, Glurich I, et al. (2005) Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res 3: 214-220.
167. Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, et al. (2001) The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 18: 971-976.
168. Mercado U, (2003) Antibody response to influenza immunization in patients with systemic lupus erythematosus. J Rheumatol 30: 2295; author reply: 2295-2296.
169. Mercado U, Acosta H, Avendano L, (2004) Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 56: 16-20.
170. Meyer S, Adam M, Ilchmann C, Eulenburg C, Sattinger E, et al. (2010) Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Transpl Int 23: 0028.
171. Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J, et al. (1989) The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 262: 779-783.
172. Miyamae T, Iwata N, Imagawa T, Mori M, Mitsuda T, et al. (2002) Efficacy and side effects of influenza vaccine for patients with pediatric rheumatic diseases under steroid and/or immunosuppressive therapy. J Pediatr Infect Dis Immunol 14: 121-124.
173. Montoya CJ, Toro MF, Aguirre C, Bustamante A, Hernandez M, et al. (2007) Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy. Mem Inst Oswaldo Cruz 102: 501-508.
174. Mulder SF, Jacobs JFM, Olde Nordkamp MAM, Kremer IK, Mulders PFA, et al. (2009) Immunological response to influenza vaccine in cancer patients undergoing treatment with sunitinib or sorafenib. Eur J Cancer 7 (Suppl): 116.
175. Nailescu C, Xu X, Zhou H, Hall H, Wilson AC, et al. (2011) Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 26: 459-467.
176. Nelson KE, Clements ML, Miotti P, Cohn S, Polk BF, (1988) The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med 109: 383-388.
177. Nicholson K, Nguyen-Van-Tam J, Ahmed A, Wiselka M, Leese J, et al. (1998) Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 351: 326-331.
178. Nordoy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, et al. (2002) Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol 19: 71-78.
179. O'Brien WA, Grovit-Ferbas K, Namazi A, Ovcak-Derzic S, Wang HJ, et al. (1995) Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86: 1082-1089.
180. Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, et al. (2008) Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis 67: 937-941.
181. Orlando G, Pariani E, Mazza F, Tanzi E, Meraviglia P, et al. (2010) Pandemic influenza vaccine in adult HIV-1-infected patients. AIDS 24: 2142-2143.
182. Ortbals DW, Liebhaber H, Presant CA, Van Amburg AL 3rd, Lee JY, (1977) Influenza immunization of adult patients with malignant diseases. Ann Intern Med 87: 552-557.
183. Pabico RC, Douglas RG, Betts RF, McKenna BA, Freeman RB, (1976) Antibody response to influenza vaccination in renal transplant patients: correlation with allograft function. Ann Intern Med 85: 431-436.
184. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD, (1996) Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 98: 196-200.
185. Pinto LA, Blazevic V, Anderson SA, Venzon DJ, Trubey CM, et al. (2001) Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects. J Infect Dis 183: 1000-1008.
186. Porter CC, Edwards KM, Zhu Y, Frangoul H, (2004) Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 42: 36-40.
187. Ragni MV, Ruben FL, Winkelstein A, Spero JA, Bontempo FA, et al. (1987) Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med 109: 545-549.
188. Rambal V, Mueller K, Nickel P, Horstrup J, Friedrich P, et al. (2010) Evaluation of Safety and Efficacy of H1N1 Swine-Origin Influenza A Vaccination in Renal Transplant Patients. Am J Transplant 10: 564-565.
189. Ramilo O, Hicks PJ, Borvak J, Gross LM, Zhong D, et al. (1996) T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infect Dis J 15: 197-203.
190. Ranieri R, Veronelli A, Santambrogio C, Pontiroli AE, (2005) Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients. AIDS Res Human Retroviruses 21: 407-409.
191. Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, et al. (2003) Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur J Haematol 70: 225-230.
192. Reboli AC, Palmer A, Byrne B, McCoy P, Chernoff D, et al. (1996) Influenza vaccination has no effect on viral load in HIV-infected patients with higher CD4 counts. Clin Infect Dis 23: 907.
193. Reid DW, Bromly CL, Stenton SC, Hendrick DJ, Bourke SJ, (1998) A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma. Respir Med 92: 1010-1011.
194. Reilly A, Kersun LS, McDonald K, Weinberg A, Jawad AF, et al. (2010) The efficacy of influenza vaccination in a pediatric oncology population. J Pediatr Hematol Oncol 32: e177-181.
195. Ristow SC, Douglas RG Jr, Condemi JJ, (1978) Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med 88: 786-789.
196. Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, et al. (2000) Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 82: 1261-1265.
197. Romanowska M, Banaszkiewicz A, Nowak I, Radzikowski A, Brydak LB, (2010) Immunization against influenza during the 2005/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD). Med Sci Monit 16: CR433-439.
198. Rosok B, Voltersvik P, Bjerknes R, Axelsson M, Haaheim LR, et al. (1996) Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin Exp Immunol 104: 203-207.
199. Rucker RP, Day NK, Good RA, Kamchaisatian W, Emmanuel P, et al. (2004) Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5. Ann Allergy Asthma Immunol 93: 272-276.
200. Rytel MW, Niebojewski RA, Rosenkranz MA, Sedmak G, (1977) Humoral and cell mediated immune response to bivalent influenza A/NJ/76 and A/Vict/75 vaccine in renal allograft recipients. Dev Biol Stand 39: 225-230.
201. Salassa B, Zucco S, Macor A, Sciullo D, Ruffatto R, et al. (1996) Influenza vaccine response in HIV patients. Int Conf AIDS 11: 121.
202. Salemi S, Picchianti-Diamanti A, Germano V, Donatelli I, Di Martino A, et al. (2010) Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin Immunol 134: 113-120.
203. Salles MJ, Sens YA, Boas LS, Machado CM, (2010) Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 24: E17-E23.
204. Sanchez-Fructuoso AI, Prats D, Naranjo P, Fernandez-Perez C, Gonzalez Ma J, et al. (2000) Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: Mycophenolate versus azathioprine. Transplantation 69: 436-439.
205. Schafer AI, Churchill WH, Ames P, Weinstein L, (1979) The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer 43: 25-30.
206. Scharpe J, Evenepoel P, Maes B, Bammens B, Claes K, et al. (2008) Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 8: 332-337.
207. Schneider MM, Sprenger MJ, Hoepelman IM, van der Graaf Y, Borleffs JC, (1996) Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1. Int J Antimicrob Agents 6: 195-200.
208. Shahgholi E, Ehsani MA, Salamati P, Maysamie A, Sotoudeh K, et al. (2010) Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy. Pediatr Blood Cancer 54: 716-720.
209. Shildt RA, Luedke DW, Kasai G, El-Beheri S, Laham MN, (1979) Antibody response to influenza immunization in adult patients with malignant disease. Cancer 44: 1629-1635.
210. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, Beyer WE, Tilanus HW, et al. (2000) Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 61: 85-93.
211. Spies CD, Kip M, Lau A, Sander M, Breuer JP, et al. (2008) Influence of vaccination and surgery on HLA-DR expression in patients with upper aerodigestive tract cancer. J Int Med Res 36: 296-307.
212. Spitaleri G, Delmonte A, Toffalorio F, De Pas TM, Gregorc V, (2010) Safety of concomitant administration of seasonal and/or H1N1 flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancer. J Thorac Oncol 5: 752-754.
213. Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, et al. (1995) Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 182: 1727-1737.
214. Steinherz PG, Brown AE, Gross PA, Braun D, Ghavimi F, et al. (1980) Influenza immunization of children with neoplastic diseases. Cancer 45: 750-756.
215. Stiver HG, Graves P, Meiklejohn G, Schroter G, Eickhoff TC, (1977) Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun 16: 738-741.
216. Stiver HG, Weinerman BH, (1978) Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Can Med Assoc J 119: 733-735, 738.
217. Sumaya CV, Williams TE, Brunell PA, (1977) Bivalent influenza vaccine in children with cancer. J Infect Dis 136 (Suppl): S656-660.
218. Takata T, Suzumiya J, Ishikawa T, Takamatsu Y, Ikematsu H, et al. (2009) Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. J Clin Exp Hematop 49: 9-13.
219. Tanzi E, Esposito S, Bojanin J, Amendola A, Trabattoni D, et al. (2006) Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy. J Med Virol 78: 440-445.
220. Tarasova AA, (2006) Effectiveness of influenza vaccination of children with rheumatic diseases. Detskie Infekzii 3: 43-46.
221. Tasker SA, O'Brien WA, Treanor JJ, Weiss PJ, Olson PE, et al. (1998) Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. Vaccine 16: 1039-1042.
222. Tasker SA, Treanor JJ, Paxton WB, Wallace MR, (1999) Efficacy of influenza vaccination in HIV-infected persons- a randomized, double-blind, placebo-controlled trial. Ann Intern Med 131: 430-433.
223. Tebas P, Frank I, Lewis M, Quinn J, Zifchak L, et al. (2010) Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. AIDS 24: 2187-2192.
224. Thibault F, Noble CP, Morelon E, Daoud S, Cahen R, et al.(2010) Safety and efficacy of an inactivated, unadjuvanted vaccine adainst the novel influenza A variant (H1N1v) in renal transplant recipients (transfluvac study). Options for the Control of Influenza VII, 3-7 September 2010, Hong Kong, SAR, China.
225. Tremblay CL, Rouleau D, Fortin C, Toma E, Sylla M, et al. (2011) Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients. Vaccine 29: 1359-1363.
226. Tsuru T, Suzaki M, Yoshio N, Mima T, Nakashima H, et al. (2008) Immune response against influenza vaccination in patients with rheumatoid arthritis undergoing IL-6 inhibition therapy (tocilizumab) compared with DMARDs. Nihon Rinsho Men'eki Gakkai Sokai Shorokushu 36: 124.
227. van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, et al. (2010) Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 62: 75-81.
228. van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, et al. (2008) Serological responses after vaccination for influenza in patients with primary humoral immunodeficiency. Clin Exp Immunol 154: 117.
229. van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, et al. (2010) Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine. Clin Immunol 136: 228-235.
230. van der Velden AM, Mulder AH, Hartkamp A, Diepersloot RJ, van Velzen-Blad H, et al. (2001) Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients. Eur J Intern Med 12: 420-424.
231. Vaziri S, Azad TM, Najafi F, Janbakhsh A, Sayyad B, et al. (2009) Surveying immunogenicity and safety of influenza vaccination in health care workers and HIV-infected individuals. Iran J Clin Infect Dis 4: 19-23.
232. Vazquez-Alvarez MD, Medrano-Lopez C, Camino-Lopez M, (2010) H1N1 influenza vaccination and infection in pediatric heart transplants. J Heart Lung Transplant 29: 1318.
233. Versluis DJ, Beyer WE, Masurel N, Weimar W, (1985) Influenza vaccination in dialysis and transplant patients. Antiviral Res Suppl 1 pp. 289-292.
234. Versluis DJ, Beyer WE, Masurel N, Wenting GJ, Weimar W, (1986) Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42: 376-379.
235. Versluis DJ, Wenting GJ, Beyer WEP, et al. (1986) Cyclosporine A impairs the humoral immune response after influenza vaccination in renal transplant recipients. Transplant Proc 18: 1348-1349.
236. Vigano A, Bricalli D, Trabattoni D, Salvaggio A, Ruzzante S, et al. (1998) Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha. AIDS Res Human Retroviruses 14: 727-734.
237. Vigano A, Zuccotti GV, Pacei M, Erba P, Castelletti E, et al. (2008) Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy. J Acquir Immune Defic Syndr 48: 289-296.
238. Weinberg GA, King JC Jr, Zangwill K, Fast PE, Wolff M, et al. (2001) Safety and immunogenicity of cold-adapted, live attenuated, influenza vaccine, trivalent (LAIV) in HIV-infected children. Pediatr Res 49: 242a.
239. Wiesik-Szewczyk E, Romanowska M, Mielnik P, Chwalinska-Sadowska H, Brydak LB, et al. (2010) Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol 29: 605-613.
240. Willcocks LC, Chaudhry AN, Smith JC, Ojha S, Doffinger R, et al. (2007) The effect of sirolimus therapy on vaccine responses in transplant recipients. Am J Transplant 7: 2006-2011.
241. Winer RL, Ellis MH, Cesario TC, Mirahmadi KS, Tilles JG, (1978) Swine influenza vaccination in transplant and dialysis patients. Dial Transplant 7: 207-210.
242. Wyzgal J, Brydak LB, Zygier D, Paczek L, Rowinski W, et al. (2002) Study on efficacy of influenza vaccination in renal allograft recipients. Transplant Proc 34: 572-575.
243. Xu Y, Methuku N, Coimbatore P, Fitzgerald T, Huang Y, et al. (2009) A prospective study of the immunogenicity of inactivated influenza A (H1N1) 2009 monovalent vaccine in patients who have solid or hematologic malignancies. 48th Annual Meeting of the Infectious Diseases Society of America, 21-24 October 2010, Vancouver, Canada. pp. Abstract 5075, poster LB-5013.
244. Yalcin S, Kondolot M, Albayrak N, Altas B, Karacan Y, et al. (2010) Serological response to influenza vaccine haematopoetic stem cell transplantation patients. Bone Marrow Transplant 45: S204.
245. Yalçin SS, Kondolot M, Albayrak N, Altas AB, Karacan Y, et al. (2010) Serological response to influenza vaccine after hematopoetic stem cell transplantation. Ann Hematol 89: 913-918.
246. Yamada A, Yamawaki H, Tsuda N, Baba K, Yabuuchi H, et al. (1982) Trial of split-product trivalent influenza vaccine in high-risk children. Biken J 25: 89-95.
247. Yamanaka H, Teruya K, Tanaka M, Kikuchi Y, Takahashi T, et al. (2005) Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients. J Acquir Immune Defic Syndr 39: 167-173.
248. Yerly S, Wunderli W, Wyler CA, Kaiser L, Hirschel B, et al. (1994) Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load. AIDS 8: 1503-1504.
249. Zuccotti GV, Cucchi C, Sala D, Giovannini M, (2002) Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children. Acta Paediatr 91: 486; author reply: 487.
250. Zuccotti GV, Zenga A, Durando P, Massone L, Bruzzone B, et al. (2004) Immunogenicity and tolerability of a trivalent virosomal influenza vaccine in a cohort of HIV-infected children. J Int Med Res 32: 492-499.
251. Zykov MP, Rafaelskaya TI, Volkon VM, Knoring BE, Shenderova RI, et al. (1980) Influenza virus vaccination of patients with pulmonary tuberculosis. Problemy Tuberkuleza 58: 3-5.
252. Zykov MP, Subbotina TI, Vishnevsky BI, Shenderova RI, Knoring BE, et al. (1983) Vaccination against influenza in patients with pulmonary tuberculosis in tuberculosis dispensaries. Problemy Tuberkuleza 61: 17-21.
253. Fine AD, Bridges CB, De Guzman AM, Glover L, Zeller B, et al. (2001) Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. Clin Infect Dis 32: 1784-1791.
254. Committee for Human Medicinal Products (2007) Guideline on influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context. EMEA/CHMP/VWP/263499/2006 London European Medicines Agency.
255. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-1108.
256. Montomoli E, (2008) Correlates of protection. In: Rappuoli R, Del Giudice G, editors. Influenza vaccines for the future Basel Berkhauser Verlag pp. 139-158.
257. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, et al. (2010) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59: 1-62.
258. Haroon M, Adeeb F, Eltahir A, Harney S, (2010) The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics. Joint Bone Spine: [Epub ahead of print].